Delivery Order 75N93020D00006-75N93020F00001
Award Date 4/1/20
Potential Completion Date 3/31/27
Potential Value $2.8M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.41 million to Bioqual, Inc. for the maintenance of non-human primates in an ABSL2/3 (Animal Biosafety Level 2/3) facility under the Simian Vaccine Evaluation Units (SVEU) program. The contract, awarded April 1, 2020, with an ultimate completion date of March 31, 2027, is structured as a cost-plus-fixed-fee delivery order with no set-aside designation. Bioqual, a for-profit biomedical...
- Bioqual, Inc. was awarded a delivery order valued at $1.41 million by the National Institute of Allergy and Infectious Diseases (NIAID) on May 1, 2013, for Simian Vaccine Evaluation Units. This cost-plus-fixed-fee contract, which concluded on April 30, 2015, was performed in Potomac, Maryland, and represents work under the broader Simian Vaccine Evaluation Units 2013-2020 indefinite delivery vehicle. No set-aside designation was applied to this award, allowing Bioqual to compete in the open...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded Bioqual, Inc. a delivery order valued at $1.89M for conducting Study P215 under the Simian Vaccine Evaluation Units (SVEUS) program. This contract, which commenced on September 8, 2021 and is scheduled for completion by August 25, 2026, employs a cost-plus-fixed-fee pricing structure and is not set aside for any particular business category. The work will be performed in Potomac, Maryland, and represents a task order...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bioqual, Inc. as the prime contractor. The contract, valued at $544,999.84, is for the housing and maintenance of non-human primates in support of biomedical research. This award falls under Bioqual's existing Simian Vaccine Evaluation Units (SVEU) indefinite-delivery/indefinite-quantity (IDIQ) contract with NIAID, which...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price delivery order contract to Bioqual, Inc., a for-profit organization, for the housing and maintenance of non-human primates for NIAID's Vaccine Research Center (VRC). The contract, which has a potential value of $882,660.21, was awarded on September 26, 2018 and is set to be completed by September 27, 2019. This award is...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $3.14 million to Bioqual, Inc. for the conduct of Study P172 under the Simian Vaccine Evaluation Units master IDIQ contract (2013-2020). This cost-plus-fixed-fee delivery order, awarded May 1, 2013, with an ultimate completion date of April 22, 2023, supports NIAID's research infrastructure for evaluating vaccine candidates and countermeasures against infectious diseases using non-human primate...
- This is a $608,420.77 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. for "SIMIAN VACCINE EVALUATION UNITS". The contract is a task order issued under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Bioqual, a for-profit organization, provides animal research support services including housing, care, and testing for...
- The U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $105,498,238.13 cost-plus-fixed-fee contract to Bioqual, Inc., a for-profit biomedical research services company located in Rockville, Maryland. The contract is for animal care and laboratory support services to the Vaccine Research Center (VRC). This is a follow-on contract to support the VRC's work in developing vaccines and therapeutics for infectious diseases, including...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit organization, to conduct a study called "CONDUCT STUDY P221." The contract has a ceiling value of $1,999,460.00 and is a delivery order under the Simian Vaccine Evaluation Units (SVEU) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle held by NIAID. The contract has an ultimate completion date of August 31, 2025...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc., a for-profit organization, to provide housing and maintenance of non-human primates for the NIAID Vaccine Research Center (NIAID-VRC). The contract has a potential value of $7,029,016.11 and a completion date of September 27, 2019. Bioqual, Inc. is an accredited company that supports...